InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Explore the complete record of transactions filed by RICKS THOMAS G, Director. Director active across 2 companies, notably Sensei Biotherapeutics, Inc.. Aggregated, 9 reports have been recorded. Total volume traded: €2.3m. The latest transaction was filed on 10 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations9 total
04,466 shares0
Common Stock
SEC:0001209191-22-036668:0·
€1m19,231 shares@ €55.61460.0063% mcap52.5% of flow
Common Stock
SEC:0001667731-22-000238:0·
€468,07510,000 shares@ €46.80750.0028% mcap23.0% of flow
Common Stock
SEC:0001667731-22-000222:0·
4,499 shares
Common Stock
SEC:0001667731-22-000218:0·
€498,34010,000 shares@ €49.8340.0030% mcap24.5% of flow
Common Stock
SEC:0001667731-22-000169:0·
19 shares
Common Stock
SEC:0001667731-22-000144:0·
Ideal exit: 26 Dec 2022 (T+270)
5,184 shares
Common Stock
SEC:0001667731-22-000087:0·
€116,69720,000 shares@ €5.83490.43% mcap100.0% of flow
Common Stock
SEC:0000899243-21-047890·
Ideal exit: 5 Sept 2022 (T+270)
€116,69720,000 shares@ €5.83490.43% mcap50.0% of flow
Common Stock
SEC:0000899243-21-047890:0·
Ideal exit: 5 Sept 2022 (T+270)
9 of 9 declarations
About RICKS THOMAS G
Thomas G. Ricks serves as a Director of Sensei Biotherapeutics, Inc. and Ovintiv Inc. As a board member, he contributes to the strategic oversight of the companies and key decision-making regarding their future. Thomas brings expertise in biotechnology and energy, which is crucial for the growth and innovation of the businesses. His commitment to corporate governance is essential for ensuring transparency and accountability.
